ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial
Lung Cancer
◽
10.1016/s0169-5002(98)90063-0
◽
1998
◽
Vol 21
◽
pp. S33
◽
Cited By ~ 1
Author(s):
V Georgoulias
◽
Ch Kourousis
◽
N Androulakis
◽
S Kakolyris
◽
MA Dimopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
Related Documents
Cited By
References
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial
Annals of Oncology
◽
10.1023/a:1008336931378
◽
2000
◽
Vol 11
(4)
◽
pp. 435-440
◽
Cited By ~ 115
Author(s):
C. Manegold
◽
U. Gatzemeier
◽
J. von Pawel
◽
R. Pirker
◽
R. Malayeri
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
◽
Pemetrexed Disodium
Download Full-text
P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284313.78584.ac
◽
2007
◽
Vol 2
(8)
◽
pp. S824
Author(s):
Andriani G. Charpidou
◽
Nikolaos Katirtzoglou
◽
Ioannis Gkiozos
◽
Eleni Karapanagiotou
◽
Anna Rigopoulou
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7263
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Author(s):
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer
Clinical Lung Cancer
◽
10.1016/j.cllc.2011.08.004
◽
2012
◽
Vol 13
(2)
◽
pp. 129-135
◽
Cited By ~ 5
Author(s):
Athanasios G. Pallis
◽
Alexandra Voutsina
◽
Nikolaos Kentepozidis
◽
Stylianos Giassas
◽
Pavlos Papakotoulas
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
Download Full-text
A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7263
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Author(s):
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.875
◽
2021
◽
Vol 16
(3)
◽
pp. S501
Author(s):
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Extensive Stage
Download Full-text
A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV
European Journal of Cancer
◽
10.1016/s0959-8049(99)81419-1
◽
1999
◽
Vol 35
◽
pp. S252
Author(s):
E. Laack
◽
T. Mende
◽
J.G. Saal
◽
A. Chemaissani
◽
J. Scholtze
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Stage Iiib
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7316
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
Author(s):
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Prolonged Infusion
Download Full-text
Paclitaxel (PTX) as second line treatment in patients (pts) with small cell lung cancer (SCLC) refractory to carboplatin - etoposide: A multicenter phase II study
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7211
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7211-7211
◽
Cited By ~ 3
Author(s):
G. Joos
◽
D. Schallier
◽
P. Pinson
◽
M. Sterckx
◽
J. P. Van Meerbeeck
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial
Lung Cancer
◽
10.1016/s0169-5002(05)80950-x
◽
2005
◽
Vol 49
◽
pp. S236-S237
Author(s):
D. Binder
◽
H. Schweisfurth
◽
C. Grah
◽
C. Schäper
◽
B. Temmesfeld-Wollbrück
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close